The UK government has commenced its first human challenge studies targeting COVID-19. Much like as occurred in places like China and Russia, healthy volunteers are…
TrialSite reported that in Russia, the Ministry of Health approved the generic form of Favipiravir, the Japanese generic of the antiviral drug Avigan. And most…
NYU Langone has just embarked on a small and targeted yet critically important pilot study. The study team now investigates new protocols to reduce the risk…
On Wednesday, US President Donald Trump suggested that the recent initiative by the FDA to tighten-up COVID-19 vaccine guidelines was politically-motivated. More specifically, POTUS declared, “That sounds…
The nation of Indonesia, the fourth most populous worldwide, has inked a deal with AstraZeneca to buy 100 million COVID-19 vaccines next year. Known as…
Researchers from Tsinghua University and Wuhan-based Union Hospital (associated with Huazhong University of Science and Technology) have developed an artificial intelligence (AI)-based system that augments…
As the COVID-19 pandemic reached the United States, the American Lung Association announced the COVID-19 Action Initiative, designed to accelerate the search for COVID-19 solutions.…
Officials from the US Department of Health and Human Services (HHS) visited with leaders from Meridian Clinical Research in Savannah, GA. Following a tour of Meridian’s internal…
Washington University School of Medicine (WUSM) in St. Louis now leads a Phase 3 clinical trial, funded by the National Institutes of Health (NIH), testing…
TrialSite shares the American Society of Health-System Pharmacists (ASHP) maintains an “Assessment of Evidence for COVID-19-Related Treatments.” Updated most recently on October 15, 2020, the…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
